• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Depression of renal clearance of furosemide in man by azotemia.

作者信息

Rose H J, O'Malley K, Pruitt A W

出版信息

Clin Pharmacol Ther. 1977 Feb;21(2):141-6. doi: 10.1002/cpt1977212141.

DOI:10.1002/cpt1977212141
PMID:837633
Abstract

The renal clearance of furosemide and tetraethylammonium (TEA) were compared in 10 patients with hypertensive nephropathy. BUN and creatinine ranges were 10 to 88 mg/dl and 0.9 to 3.8 mg/dl, respectively. Diuretics were discontinued 48 hr prior to the study, and 2 consecutive clearances (ml/min/1.73 m2BSA) of creatinine were performed. The patient then received a bolus followed by a constant infusion of furosemide-14C and tetraethylammonium-14C (analyzed by specific methodology for plasma and urine), both in subpharmacologic doses. After 40-min equilibration sequential 20-min clearance periods were obtained. Both the clearance of furosemide (range 17 to 133) and TEA (range 99 to 443) correlated negatively with BUN and serum creatinine and positively with creatinine and urea clearances. Thus, by using a constant-infusion technique we demonstrated that the renal clearance of furosemide is depressed by azotemia in man and that there was greater depression with furosemide than with TEA.

摘要

相似文献

1
Depression of renal clearance of furosemide in man by azotemia.
Clin Pharmacol Ther. 1977 Feb;21(2):141-6. doi: 10.1002/cpt1977212141.
2
Effect of experimental azotemia on renal clearance of furosemide in the dog.实验性氮质血症对犬呋塞米肾清除率的影响。
J Pharmacol Exp Ther. 1976 Jan;196(1):238-47.
3
Relationship of urinary furosemide excretion rate to natriuretic effect in experimental azotemia.
J Pharmacol Exp Ther. 1976 Dec;199(3):490-7.
4
Effects of azotemia on renal extraction and clearance of PAH and TEA.
Am J Physiol. 1976 Apr;230(4):901-6. doi: 10.1152/ajplegacy.1976.230.4.901.
5
Prerenal azotemia: differentiation of hyperureagenesis from renal hypoperfusion using urinary urea nitrogen data.肾前性氮质血症:利用尿尿素氮数据鉴别高尿素生成与肾灌注不足。
Int J Artif Organs. 1996 Mar;19(3):164-9.
6
Evaluation of blood urea nitrogen and serum creatinine concentrations as indicators of renal dysfunction: a study of 111 cases and a review of related literature.评估血尿素氮和血清肌酐浓度作为肾功能不全指标的研究:111例病例分析及相关文献综述
J Am Vet Med Assoc. 1976 Apr 1;168(7):593-601.
7
Determinants of the renal clearance of digoxin.地高辛肾清除率的决定因素。
Clin Pharmacol Ther. 1975 Apr;17(4):385-94. doi: 10.1002/cpt1975174385.
8
The value of aggressive therapy in the hypertensive patient with azotemia.积极治疗对伴有氮质血症的高血压患者的价值。
Circulation. 1969 Dec;40(6):893-904. doi: 10.1161/01.cir.40.6.893.
9
Continuous infusion of furosemide combined with low-dose dopamine compared to intermittent boluses in acutely decompensated heart failure is less nephrotoxic and carries a lower readmission at thirty days.与间断推注相比,急性失代偿性心力衰竭中连续输注呋塞米联合小剂量多巴胺的肾毒性较小,且在 30 天时再入院率较低。
Hellenic J Cardiol. 2011 May-Jun;52(3):227-35.
10
[Differences between the glomerular filtration rate estimated by the MDRD equation and the measurement of creatinine and urea clearance in unselected patients with terminal renal insufficiency].[MDRD方程估算的肾小球滤过率与未选择的终末期肾功能不全患者肌酐和尿素清除率测定值之间的差异]
Nefrologia. 2002;22(5):432-7.

引用本文的文献

1
The furosemide stress test: current use and future potential.速尿激发试验:当前应用和未来潜力
Ren Fail. 2021 Dec;43(1):830-839. doi: 10.1080/0886022X.2021.1906701.
2
Human albumin infusion for treating oedema in people with nephrotic syndrome.输注人白蛋白治疗肾病综合征患者的水肿
Cochrane Database Syst Rev. 2019 Jul 12;7(7):CD009692. doi: 10.1002/14651858.CD009692.pub2.
3
Diuretic Resistance in Heart Failure.心力衰竭中的利尿剂抵抗
Curr Heart Fail Rep. 2019 Apr;16(2):57-66. doi: 10.1007/s11897-019-0424-1.
4
Diuretic combinations in refractory oedema states: pharmacokinetic-pharmacodynamic relationships.难治性水肿状态下的利尿剂联合应用:药代动力学-药效学关系
Clin Pharmacokinet. 1996 Mar;30(3):229-49. doi: 10.2165/00003088-199630030-00004.
5
Furosemide disposition in patients on CAPD.持续性非卧床腹膜透析患者中呋塞米的处置情况
Eur J Clin Pharmacol. 1995;48(5):385-90. doi: 10.1007/BF00194955.
6
Torasemide in advanced renal failure.托拉塞米用于晚期肾衰竭。
Cardiovasc Drugs Ther. 1993 Jan;7 Suppl 1:75-80. doi: 10.1007/BF00877961.
7
Pharmacokinetic changes in patients with oedema.水肿患者的药代动力学变化。
Clin Pharmacokinet. 1995 May;28(5):405-18. doi: 10.2165/00003088-199528050-00005.
8
Diuretic strategies in patients with renal failure.肾衰竭患者的利尿策略。
Drugs. 1994 Sep;48(3):380-5. doi: 10.2165/00003495-199448030-00005.
9
Measurement of the renal clearance of drugs.药物肾清除率的测定。
Br J Clin Pharmacol. 1981 Dec;12(6):761-70. doi: 10.1111/j.1365-2125.1981.tb01304.x.
10
Resistance to diuretics: emphasis on a pharmacological perspective.利尿剂抵抗:从药理学角度的重点阐述
Drugs. 1981 Dec;22(6):477-94. doi: 10.2165/00003495-198122060-00004.